178.85
0.70%
+1.24
Overview
News
Price History
Option Chain
Why RMD Down?
Discussions
Forecast
Stock Split
Dividend History
Resmed Inc. stock is currently priced at $178.85, with a 24-hour trading volume of 1.28M.
It has seen a +0.70% increased in the last 24 hours and a -7.34% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $177.9 pivot point. If it approaches the $179.5 resistance level, significant changes may occur.
Resmed Inc. Stock (RMD) Financials Data
Resmed Inc. (RMD) Revenue 2024
RMD reported a revenue (TTM) of $4.50 billion for the quarter ending December 31, 2023, a +19.69% rise year-over-year.
Resmed Inc. (RMD) Net Income 2024
RMD net income (TTM) was $890.39 million for the quarter ending December 31, 2023, a +10.00% increase year-over-year.
Resmed Inc. (RMD) Cash Flow 2024
RMD recorded a free cash flow (TTM) of $943.73 million for the quarter ending December 31, 2023, a +325.82% increase year-over-year.
Resmed Inc. (RMD) Earnings per Share 2024
RMD earnings per share (TTM) was $6.05 for the quarter ending December 31, 2023, a +9.80% growth year-over-year.
Resmed Inc. Stock (RMD) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Rider Michael J | Global General Counsel |
Mar 04 '24 |
Sale |
180.00 |
81 |
14,580 |
6,607 |
Rider Michael J | Global General Counsel |
Mar 01 '24 |
Sale |
173.25 |
200 |
34,650 |
6,688 |
FARRELL PETER C | Director |
Feb 22 '24 |
Sale |
182.66 |
10,935 |
1,997,434 |
157,404 |
Sandercock Brett | Chief Financial Officer |
Nov 27 '23 |
Sale |
152.62 |
3,000 |
457,860 |
92,962 |
Farrell Michael J. | Chief Executive Officer |
Nov 15 '23 |
Option Exercise |
57.76 |
5,678 |
327,961 |
446,664 |
Farrell Michael J. | Chief Executive Officer |
Nov 15 '23 |
Sale |
152.04 |
5,678 |
863,281 |
440,986 |
Rider Michael J | Global General Counsel |
Nov 01 '23 |
Sale |
143.42 |
25 |
3,585 |
7,358 |
Farrell Michael J. | Chief Executive Officer |
Oct 16 '23 |
Option Exercise |
57.76 |
5,675 |
327,788 |
455,035 |
Farrell Michael J. | Chief Executive Officer |
Oct 16 '23 |
Sale |
140.70 |
5,675 |
798,464 |
449,360 |
Rider Michael J | Global General Counsel |
Oct 02 '23 |
Sale |
145.92 |
25 |
3,648 |
7,383 |
Resmed Inc. Stock (RMD) Latest News
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks Investment Research
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
The Motley Fool
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
Benzinga
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
GlobeNewswire Inc.
5 Medical Product Stocks to Buy Amid Industry Challenges
Zacks Investment Research
Here's Why Investors Should Buy ResMed (RMD) Stock Now
Zacks Investment Research
About Resmed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Cap:
|
Volume (24h):